Metronidazole

Metronidazole is a member of the nitroimidazole family of antimicrobials, and it is unusual in being active against both anaerobic bacteria, which live without oxygen, and several disease-causing protozoa ^[1][2]. It is a small synthetic molecule that is well absorbed by mouth and distributes widely through the body, reaching tissues including the central nervous system ^[3]. As the prototype of its class, it has been in continuous use for decades and remains a standard treatment for anaerobic infection ^[2].

Metronidazole was developed by the French company Rhone-Poulenc in the late 1950s and first came into use around 1960, initially for the sexually transmitted parasite Trichomonas vaginalis ^[1][3]. Its usefulness was soon extended to other protozoal diseases and to infections caused by anaerobic bacteria, and it has since become one of the most important drugs for these purposes ^[2][3]. The original patent expired in the early 1980s, and it is now an inexpensive generic ^[1].

Metronidazole treats a wide range of infections in which anaerobic organisms play a part ^[1][2]. Common uses include bacterial vaginosis and pelvic infections, trichomoniasis, the intestinal parasites that cause giardiasis and amoebiasis, dental and abdominal anaerobic infections, and, as part of combination regimens, the eradication of the stomach bacterium Helicobacter pylori ^[1][2]. It has long been a treatment for Clostridioides difficile colitis, although newer agents are now often preferred ^[1]. Applied to the skin, it is a mainstay topical treatment for rosacea ^[1]. Reviews describe it as a cost-effective, well-established drug against which resistance has remained relatively uncommon, so it continues to be regarded as a standard for anaerobic infection ^[2].

Metronidazole is a prescription medicine on the World Health Organization's Model List of Essential Medicines, available as oral tablets and capsules, intravenous solution, and vaginal and skin preparations ^[1][3]. It is generally well tolerated, with a metallic taste, nausea, and headache among the more frequent complaints ^[1]. A well-known caution is its interaction with alcohol: drinking during treatment has been reported to cause an unpleasant disulfiram-like reaction with flushing, nausea, and a racing heart, so alcohol is usually avoided ^[1]. Prolonged or high-dose use can rarely lead to nerve damage, and the drug can interact with blood thinners such as warfarin because it inhibits a liver enzyme; regulatory bodies have flagged evidence of cancer in animal studies, though its significance for humans remains unclear ^[1].

Metronidazole is prescription only. Common effects include nausea, a sharp metallic taste, headache, and stomach upset. The classic warning is to avoid alcohol during treatment and for a few days after, since the pair can cause flushing, vomiting, and a racing heart. Long or high-dose courses can cause reversible nerve tingling in the hands and feet, and rarely central effects such as confusion or unsteadiness. It can boost the blood thinner warfarin and interacts with lithium and phenytoin. It is generally avoided in the first trimester of pregnancy unless clearly needed, and it may darken the urine, which is harmless.

The alcohol interaction is the one people hear about. Metronidazole inhibits aldehyde dehydrogenase, and drinking during or shortly after a course has been linked to a disulfiram-like reaction of flushing, vomiting, cramping and tachycardia. The evidence is weaker than the warning's prominence suggests, but it stands, and it extends to medicines formulated with propylene glycol. Disulfiram itself is a different matter: taken together the two have produced acute confusion and psychosis, and labeling separates them by two weeks.

Warfarin is the more consequential interaction. Metronidazole inhibits CYP2C9, which clears the more potent S enantiomer, so INR climbs and serious bleeding has followed. Lithium concentrations rise during short metronidazole courses, sometimes into the toxic range with tremor and confusion. Metronidazole also increases busulfan exposure enough to be dangerous during transplant conditioning. Additive QT prolongation with other QT prolonging drugs rounds out the list.

Checking a whole stack? Run it through interactions + stacks.

Metronidazole was discovered in the late 1950s by researchers at the French company Rhone-Poulenc, who were pursuing synthetic relatives of azomycin, a naturally occurring 2-nitroimidazole antibiotic that had been isolated from a soil Streptomyces. The team produced the 5-nitroimidazole that became metronidazole and first introduced it around 1960 as a targeted treatment for the sexually transmitted parasite Trichomonas vaginalis, an indication for which it proved highly effective.

A now-famous piece of serendipity soon broadened its reach: a patient treated for trichomoniasis was noticed to have also cleared a case of gum disease, hinting at activity against anaerobic bacteria, and over the following years the drug was shown to treat amoebiasis, giardiasis, and a wide range of serious anaerobic infections. Marketed most widely as Flagyl, it became a cornerstone antimicrobial and is used topically as well, for instance in rosacea. Its selective action against oxygen-poor microbes, which spares human cells, underlies both its effectiveness and its enduring place among essential antimicrobial medicines.

Metronidazole is one of the quiet giants of the antibiotic world, an inexpensive and reliable drug that remains the treatment of choice for a whole category of infections that many other antibiotics simply cannot touch. Its elegance lies in a built-in selectivity: it arrives as an inert prodrug and becomes toxic only inside the strongly oxygen-poor interior of anaerobic bacteria and certain parasites, so it strikes the target while largely sparing the patient's own aerobic cells.

That precision has made it indispensable against bacterial vaginosis, trichomoniasis, giardiasis, amoebiasis, and dangerous anaerobic and dental infections, and it works throughout the body as well as on the skin. In fairness, it comes with well-known quirks, including a metallic taste, gastrointestinal upset, and a sharp interaction with alcohol that can cause an unpleasant flushing reaction. Decades after its debut, it remains a trusted, first-line, and genuinely clever antimicrobial.